Trial · NCT07898280
Smartphone-Based Self-Registration of Health Data in Patients With Severe Unspecific Symptoms or Cancer of Unknown Primary
NCT07898280, Not applicable, Not yet recruiting, University of Skövde
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Smartphone-Based Self-Registration of Health Data in Patients With Severe Unspecific Symptoms or Cancer of Unknown Primary. Trials, record NCT07898280. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898280
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Smartphone-Based Self-Registration of Health Data in Patients With Severe Unspecific Symptoms or Cancer of Unknown Primary
- NCT number
- NCT07898280
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 200 participants, estimated
- Lead sponsor
- University of Skövde
- Conditions
- Advanced Unspecific Symptom, Cancer of Unknown Primary Site
- Interventions
- Smartphone app enabling self-registration of physical and mental health
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Perceived benefit of app-supported self-registration to the diagnostic procedure, as assessed by care staff questionnaire | Upon conclusion of the diagnostic work-up (up to 12 weeks after enrollment) | For each patient in the intervention arm, the treating physician completes a study-specific questionnaire at the conclusion of the diagnostic work-up. The primary reported value is the care staff rating of the extent to which the patient's access to the Previct Mind application influenced decisions made within the diagnostic procedure, on a 5-point ordinal scale where 1 indicates no influence and 5 indicates great influence. Higher scores indicate greater perceived benefit to the diagnostic procedure. |
| Secondary | Patient-rated engagement and empowerment, as assessed by study-specific patient questionnaires | Upon conclusion of the diagnostic work-up (up to 12 weeks after enrollment) | All study subjects (intervention and reference arms) complete a study-specific questionnaire at the conclusion of the diagnostic work-up, rating (a) their engagement in the care received at the Diagnostic Center on a 5-point scale where 1 indicates little engagement and 5 indicates great engagement, and (b) their preference for more or less engagement, on a 5-point scale where 1 indicates a desire for much less engagement and 5 for much more engagement. Higher scores indicate greater perceived engagement and empowerment. Scores are compared between the intervention and reference arms. |
| Secondary | Time from enrollment to concluded diagnosis | From enrollment to concluded diagnosis (up to 12 weeks after enrollment) | Time from enrollment to the concluded diagnosis determined within care as usual, extracted from medical records, compared between the intervention arm, the reference arm, and the retrospective cohort. |
| Secondary | Accuracy of an artificial intelligence or machine learning model in classifying underlying disease severity | Through study completion, assessed once after all participants have completed the diagnostic work-up. | An artificial intelligence or machine learning model will be trained on collected data (medical history, biomarker panel results, and self-reported physical and mental health) to classify study subjects as having (1) serious disease warranting referral to the Diagnostic Center, or (2) mild disease not warranting referral. Performance is reported as Area Under the Curve (AUC) of a Receiver-Operator Characteristics (ROC) graph. |
| Secondary | Incidence and severity of adverse events associated with data collection and use of the smartphone application | From enrollment to completion of the diagnostic work-up (up to 12 weeks after enrollment) | Incidence and severity of adverse events associated with data collection and use of the application, including determination of causality. Severity is graded on a 5-point scale ranging from mild (asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated) to death related to the adverse event. Per the protocol, adverse events attributable to this study are anticipated to be mainly limited to privacy infringement, as all medical procedures are conducted as part of care as usual. Incidence and severity of adverse events will be reported in a table. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898280
GET https://conductscience.org/api/trials/v1/NCT07898280/registered